| Researchers in California believe they have hit the jackpot in modern medical breakthroughs. The cure for AIDS. |
| researchers were able to isolate the antibodies that neutralize a high percentage of the virus’s different forms currently in circulation worldwide. |
| Now that these antibodies have been discovered, it is only a matter of finding out if people at large can produce these antibodies themselves after exposure to the vaccine. |
| These new antibodies target a region of the virus which is used to infect our cells. These regions have become highly variable to ward off attacks from our bodies immune system, but the excitement around this new antibody is that it appears to target regions of this protein that remain the same in almost all strains of HIV. |
| Researchers are hopeful that this new screening technique will help them discover even more broadly neutralizing antibodies in the future.Read more at planetsave.com |
| Biotech company Novavax, Inc., says the most recent trial testing its seasonal flu vaccine–made using virus-like particles rather than fertilized chicken eggs–was encouraging in that the vaccine significantly boosted antibody titers in the majority of participants. |
| Novavax says that during Phase IIa of seasonal flu vaccine testing, which began in May, it was able in the majority of people tested to surpass the FDA’s requirements for producing enough antibodies to protect the body from the H3N2, H1N1 and B viruses—all of which were common enough a year ago to be used to develop flu vaccines for the 2008 to 2009 flu season.Read more at www.scientificamerican.com |
| “The success of this trial gives us the support that we need for Phase III,” says Penny Heaton, Novavax’s chief medical officer and vice president of development. “It’s very encouraging.” |
|
